Studies have shown that bile salts facilitate the development of CCA by inducing biliary proliferation, promoting liver inflammation, downregulating FXR and upregulating GPBAR1 (Deutschmann et al., 2018). Here, GPBAR1 is linked to cholangiocarcinoma.